Tardive dyskinesia: A clinical test of the supersensitivity hypothesis
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 61 (2) , 137-141
- https://doi.org/10.1007/bf00426727
Abstract
Patients with tardive dyskinesia showed no significant difference in CSF HVA when compared with groups of schizophrenic or depressives. CSF cAMP in the tardive dyskinesia group was significantly lower when compared to schizophrenics but not depressives. These results do not support a dopamine-receptor supersensitivity hypothesis in permanent tardive dyskinesia.Keywords
This publication has 52 references indexed in Scilit:
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatmentJournal of Neurochemistry, 1977
- Release of cerebral cyclic AMP into push-pull perfusates in freely moving ratsBrain Research, 1976
- An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patientsLife Sciences, 1976
- Cholinergic and dopaminergic mechanisms in Huntington's choreaLife Sciences, 1971
- Rapid elevation of biogenic amine metabolites in human CSF following probenecidLife Sciences, 1970
- The effect of L-Dopa on monoamine metabolites in Parkinson's diseaseCellular and Molecular Life Sciences, 1970
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964